{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:13:56Z","timestamp":1754194436055},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1091,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1365-2133.2012.11067.x","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T16:21:19Z","timestamp":1337962879000},"page":"914-921","source":"Crossref","is-referenced-by-count":4,"title":["Differential effects of colchicine in blood mononuclear cells of patients with Beh\u00e7et disease in relation to colchicine responsiveness"],"prefix":"10.1093","volume":"167","author":[{"given":"M.Y.","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-010-1566-4","article-title":"Evaluation of current therapeutic strategies in Beh\u00e7et\u2019s disease","volume":"30","author":"Alexoudi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Beh\u00e7et\u2019s disease - a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010053622894","article-title":"Beh\u00e7et\u2019s disease as an autoinflammatory disorder","volume":"4","author":"Gul","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-003-0400-6","article-title":"Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Beh\u00e7et\u2019s disease","volume":"25","author":"Duzgun","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et\u2019s syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3181\/00379727-104-25809","article-title":"Inhibition of neutrophil mobilization by colchicine","volume":"104","author":"Fruhman","year":"1960","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1074\/jbc.M006814200","article-title":"ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage","volume":"276","author":"Mehta","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tcb.2009.06.002","article-title":"Molecular mechanisms involved in inflammasome activation","volume":"19","author":"Bryant","year":"2009","journal-title":"Trends Cell Biol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2936","article-title":"Emerging inflammasome effector mechanisms","volume":"11","author":"Lamkanfi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"33963","DOI":"10.1074\/jbc.M111.286823","article-title":"Caspase-1 protein induces apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)-mediated necrosis independently of its catalytic activity","volume":"286","author":"Motani","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB14|cit14","first-page":"L315","article-title":"Colchicine has opposite effects on interleukin-1 beta and tumor necrosis factor-alpha production","volume":"261","author":"Allen","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00296-005-0040-0","article-title":"Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Beh\u00e7et\u2019s disease. Does interleukin-1beta play a major role in Beh\u00e7et\u2019s synovitis?","volume":"26","author":"Pay","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","article-title":"Interleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Beh\u00e7et\u2019s disease: an open-label pilot study","volume":"71","author":"Gul","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB18|cit18","first-page":"712","article-title":"The activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1beta under acidic extracellular pH in LPS-primed microglial cells","volume":"117","author":"Takenouchi","year":"2011","journal-title":"J Neurochem"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.181.5.1917","article-title":"Granzyme A is an interleukin 1 beta-converting enzyme","volume":"181","author":"Irmler","year":"1995","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.20071632","article-title":"Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8","volume":"205","author":"Maelfait","year":"2008","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1016\/S0021-9258(20)89612-4","article-title":"Structure-function mapping of interleukin 1 precursors. Cleavage leads to a conformational change in the mature protein","volume":"266","author":"Hazuda","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.96.11.6261","article-title":"Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3","volume":"96","author":"Coeshott","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1002\/art.24959","article-title":"Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation","volume":"60","author":"Guma","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/art.25006","article-title":"Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta","volume":"60","author":"Joosten","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB26|cit26","first-page":"1540","article-title":"Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever","volume":"34","author":"Tufan","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/S0049-0172(03)00137-9","article-title":"Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization","volume":"33","author":"Lidar","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB28|cit28","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0198-8859(86)90281-8","article-title":"Beh\u00e7et\u2019s disease associated with HLA-B51 and DRw52 antigens in Italians","volume":"17","author":"Baricordi","year":"1986","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2133.2006.07348.x","article-title":"TNF-alpha gene 1031 T\/C polymorphism in Turkish patients with Beh\u00e7et\u2019s disease","volume":"155","author":"Akman","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11067.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10165-011-0497-5","article-title":"A case of Beh\u00e7et\u2019s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab","volume":"22","author":"Hirano","year":"2012","journal-title":"Mod Rheumatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11067.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11067.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:56:15Z","timestamp":1676382975000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/4\/914\/6614203"}},"subtitle":["Colchicine effects in Beh\u00e7et disease colchicine nonresponders"],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11067.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,5]]}}}